- This topic has 1 reply, 1 voice, and was last updated 4 months ago by
.
Viewing 1 reply thread
-
Posts
-
-
Over my 40 years with MS I’ve been treated with four disease-modifying therapies: Avonex, Tysabri, Aubagio and Lemtrada. Sometimes a wash-out period was needed – sometimes not – but being treated with one never seemed to impact my treatment with another. Here’s a report on a study about making the switch to one of my quartet of treatments.
What’s been your experience?
-
Rebif & Copaxone. Body rejected both.
Gilenya [Fingolimod] – loved but MS eventually broke thru!
Lemtrada. Awful experience: https://multiplesclerosisnewstoday.com/2017/05/26/ms-lemtrada-and-immobility-this-island-couch-series-part-i/
Ocrevus – which I also really liked but destroyed my immune system!!
Now on nothing. Waiting on experimental drug suggested by me Neurologist…..
….
-
Viewing 1 reply thread
- You must be logged in to reply to this topic.
